Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma.
会议论文
Wang Kefeng,Wu Duoguang,Wang Wenjian, et al. Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma. [J].JOURNAL OF CLINICAL ONCOLOGY,2023,41(16_SUPPL):E16030-E16030.
APA：
Wang Kefeng,Wu Duoguang,Wang Wenjian,Lei Kai,&Wang Minghui.(2023).Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma. .JOURNAL OF CLINICAL ONCOLOGY,41(16_SUPPL):E16030-E16030.
MLA：
Wang Kefeng, et al. "Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma." .JOURNAL OF CLINICAL ONCOLOGY 41,16_SUPPL(2023):E16030-E16030.
Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma.
作者：
Wang, Kefeng ;Wu, Duoguang ;Wang, Wenjian ;Lei, Kai ;Liang, Ruihao ;Tan, Binghua ;Hu, Xueting ;Li, Lin ;Lyu, Yingcheng ;Wang, Zhizheng ;Zeng, Yanwu ;Pang, Fei ;Wang, Kai ;Lin, Huayue ;Wang, Minghui
来源出版物：
JOURNAL OF CLINICAL ONCOLOGY
2023 年41 卷16_SUPPL 期(E16030 - E16030)
文献号：
e16030
增刊：
16_SUPPL
出版日期：
2023 JUN 1
ISSN/EISSN：
0732-183X /1527-7755
地址：
Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China. Shanghai OrigiMed Co Ltd, Shanghai, Peoples R China. Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Thorac Surg, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China.
(8.0+极速模式)